Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
Yosuke Togashi,1 Hidetoshi Hayashi,1–3 Kazuhiko Nakagawa,2 Kazuto Nishio1 1Department of Genome Biology, 2Department of Medical Oncology, Kindai University Faculty of Medicine, 3Department of Medical Oncology, Kishiwada Municipal Hospital, Osaka, Japan Abstract: Gefitinib, an epidermal g...
Main Authors: | Togashi Y, Hayashi H, Nakagawa K, Nishio K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/clinical-utility-of-erlotinib-for-the-treatment-of-non-small-cell-lung-peer-reviewed-article-DDDT |
Similar Items
-
Erlotinib for the treatment of relapsed non-small cell lung cancer
by: C McLeod, et al.
Published: (2009-06-01) -
Experience with erlotinib in the treatment of non-small cell lung cancer
by: Lorenza Landi, et al.
Published: (2015-08-01) -
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
by: Boutsikou E, et al.
Published: (2013-03-01) -
Clinical Observation of Erlotinib in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
by: Haiqing YUAN, et al.
Published: (2009-07-01) -
Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
by: Renhua GUO, et al.
Published: (2009-12-01)